Treatment of Chronic Delta Hepatitis With Lonafarnib.

Trial Profile

Treatment of Chronic Delta Hepatitis With Lonafarnib.

Completed
Phase of Trial: Phase II

Latest Information Update: 15 Sep 2016

At a glance

  • Drugs Lonafarnib (Primary)
  • Indications Hepatitis D
  • Focus Proof of concept; Therapeutic Use
  • Most Recent Events

    • 17 Apr 2016 Pharmacokinetic, pharmacodynamics and viral kinetic results presented at The International Liver Congress™ 2016.
    • 20 Jul 2015 Results published in an Eiger BioPharmaceuticals media
    • 20 Jul 2015 According to an Eiger BioPharmaceuticals media release, data from this study were published in The Lancet Infectious Diseases.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top